癌症中的替代拼接和循环RNA之间的交叉:致病性见解和治疗影响
Hongkun Hu1, Jinxin Tang1, Hua Wang1
1Department of Orthopaedics, Hunan Key Laboratory of Tumor Models and Individualized Medicine, Hunan Engineering Research Center of Artificial Intelligence-Based Medical Equipment, The Second Xiangya Hospital of Central South University, Changsha, 410011, China.
Cellular & molecular biology letters
|November 16, 2024
概括
替代拼接 (AS) 和循环RNAs (circRNAs) 在癌症中失调. 这篇评论探讨了它们的复杂相互作用,揭示了它们如何相互调节并促进癌症进展.
科学领域:
- 分子生物学分子生物学
- 癌症生物学 癌症生物学
- 基因表达规范 基因表达规范
背景情况:
- 替代拼接 (AS) 从单个基因产生多种不同的RNA变体.
- 循环RNAs (circRNAs) 是通过一种叫做背接的特定类型的AS形成的.
- 在癌症中,AS和circRNA生物发生变化,影响细胞功能.
研究的目的:
- 审查癌症中替代拼接和循环RNA之间的复杂关系.
- 总结一下拼接因子和RNA结合蛋白如何调节circRNA生物发生.
- 阐明circRNAs如何影响替代拼接事件并对瘤发生产生贡献.
主要方法:
- 关于研究AS和癌症中circRNAs之间的交叉通话的文献综述.
- 对涉及拼接因子,RNA结合蛋白和表观遗传修饰的调节机制的分析.
- 对癌症进展中circRNAs和AS之间的反循环的当前知识的综合.
主要成果:
- AS调节circRNA生物发生,而circRNA反过来调节AS事件.
- 表观遗传和转录后修饰同时影响AS和circRNAs.
- 循环RNA和AS之间的反循环对瘤发生和癌症进展有显著的贡献.
结论:
- 了解AS和circRNAs之间的交叉声提供了对癌症生物学的关键见解.
- 准AS-circRNA轴为癌症治疗提供了潜在的新策略.
相关概念视频
RNA Splicing
56.0K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.0K
Alternative RNA Splicing
21.0K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.0K
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Chromatin Structure Regulates pre-mRNA Processing
6.9K
In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
The chromatin structure, especially...
6.9K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Rous Sarcoma Virus (RSV) and Cancer
5.0K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.0K


